Allworth Financial
EWTX icon

Allworth Financial’s Edgewise Therapeutics EWTX Stock Holding History

Allworth Financial’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.15K Buy
176
+92
+110% +$3.17K ﹤0.01% 3931
2026
Q1 		$2.65K Buy
84
+28
+50% +$807 ﹤0.01% 4253
2025
Q4 		$1.39K Buy
56
+23
+70% +$462 ﹤0.01% 4254
2025
Q3 		$536 Buy
+33
New +$468 ﹤0.01% 4417
2024
Q3 		– Sell
-45
Closed -$962 – 3772
2024
Q2 		$962 Hold
45
– – ﹤0.01% 3178
2024
Q1 		$821 Hold
45
– – ﹤0.01% 3144
2023
Q4 		$493 Buy
+45
New +$316 ﹤0.01% 3130
2023
Q3 		– Sell
-221
Closed -$1.71K – 3472
2023
Q2 		$1.71K Buy
+221
New +$1.86K ﹤0.01% 2542

Other funds holding EWTX

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Allworth Financial's EWTX Position: Q2 2026 in Review

Allworth Financial increased its Edgewise Therapeutics (EWTX) stake by 110% in Q2 2026, buying an estimated $3.17K and bringing the position to 176 shares worth $7.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3931.

Allworth Financial first reported a position in EWTX in Q2 2023 and has held it in 8 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Allworth Financial held 176 shares of Edgewise Therapeutics worth $7.15K as of Q2 2026.
  • Allworth Financial bought 92 Edgewise Therapeutics shares in Q2 2026, an estimated $3.17K.
  • Edgewise Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3931 holding.
  • Allworth Financial first reported a position in Edgewise Therapeutics in Q2 2023 and has held it in 8 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.